KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dynavax Technologies (DVAX) Non-Current Debt (2018 - 2021)

Historic Non-Current Debt for Dynavax Technologies (DVAX) over the last 9 years, with Q1 2021 value amounting to $179.9 million.

  • Dynavax Technologies' Non-Current Debt rose 17.04% to $179.9 million in Q1 2021 from the same period last year, while for Mar 2021 it was $179.9 million, marking a year-over-year increase of 17.04%. This contributed to the annual value of $179.8 million for FY2020, which is 67.75% up from last year.
  • Per Dynavax Technologies' latest filing, its Non-Current Debt stood at $179.9 million for Q1 2021, which was up 17.04% from $179.8 million recorded in Q4 2020.
  • Over the past 5 years, Dynavax Technologies' Non-Current Debt peaked at $179.9 million during Q1 2021, and registered a low of $99.2 million during Q1 2018.
  • Its 4-year average for Non-Current Debt is $154.4 million, with a median of $177.6 million in 2019.
  • In the last 5 years, Dynavax Technologies' Non-Current Debt soared by 7705.88% in 2019 and then rose by 17.04% in 2021.
  • Dynavax Technologies' Non-Current Debt (Quarter) stood at $100.9 million in 2018, then skyrocketed by 77.06% to $178.6 million in 2019, then grew by 0.68% to $179.8 million in 2020, then increased by 0.04% to $179.9 million in 2021.
  • Its Non-Current Debt was $179.9 million in Q1 2021, compared to $179.8 million in Q4 2020 and $179.7 million in Q3 2020.